Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes

BACKGROUND: Cerium dioxide (CeO(2)) nanoparticles have potential therapeutic applications and are widely used for industrial purposes. However, the effects of these nanoparticles on primary human cells are largely unknown. The ability of nanoparticles to exacerbate pre-existing inflammatory disorder...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hussain, Salik, Al-Nsour, Faris, Rice, Annette B, Marshburn, Jamie, Ji, Zhaoxia, Zink, Jeffery I, Yingling, Brenda, Walker, Nigel J, Garantziotis, Stavros
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3310407/
https://ncbi.nlm.nih.gov/pubmed/22457596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S29429
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars